Chu, I M <br/><br/>
GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells.  [electronic resource] 

 -  Oncogene  Apr 2012 
 - 2017-27 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2011.382  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--metabolism<br/>Cell Line, Tumor<br/>Female<br/>GATA3 Transcription Factor--metabolism<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Neoplasm Metastasis--prevention & control<br/>Neoplasms, Basal Cell--metabolism<br/>Neoplasms, Hormone-Dependent--metabolism<br/>Prognosis<br/>Protein-Lysine 6-Oxidase--antagonists & inhibitors<br/>Pyrimidines<br/>Thiophenes